Which is more profitable, Eli Lilly or Natera?

Eli Lilly keeps more of every sale as profit.

Which grows faster, Eli Lilly or Natera?

Natera grew its sales faster in recent years.

Which is cheaper, Eli Lilly or Natera?

Eli Lilly costs less for each unit of yearly profit (lower P/E).

Which has less debt, Eli Lilly or Natera?

Natera would need fewer years of earnings to pay off its debt.

Eli LillyLLYvs

NateraNTRA

Eli Lilly vs Natera stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Eli Lilly is more profitable and is cheaper for its profits. Natera grows faster and has less debt.

Side by side

	Eli Lilly	Natera
	$1.29 trillion	$46.3 billion
	31.7%	-9.0%
	+21.6%	+42.6%
	62.3×	No profit yet
	1.1 years	Net cash
	34.8%	-11.1%
	0.6%	–

Open Eli Lilly Open Natera

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Eli Lilly vs Novo Nordisk · Eli Lilly vs Novartis · Eli Lilly vs Pfizer · Eli Lilly vs Regeneron Pharmaceuticals · Natera vs Quest Diagnostics · Natera vs Labcorp Holdings